| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 6 | -914K | 100% | $29.55 | -$27M |
| Net | -6 | -914K | -100% | -$27M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Andrew Cheng | President and CEO, Director | $21.6M | -$10.1M | -31.9% | Dec 16, 2024 |
| Jonathan Young | Chief Operating Officer | $15.5M | -$4.41M | -22.1% | Dec 16, 2024 |
| Timothy Rolph | Chief Scientific Officer | $6.17M | -$353K | -5.41% | Dec 16, 2024 |
| Catriona Yale | Chief Development Officer | $2.78M | -$3.87M | -58.2% | Dec 16, 2024 |
| Skorpios Trust | Former 10% owner | $2.01M | Dec 1, 2022 | ||
| William Richard White | Chief Financial Officer | $1.95M | -$8.2M | -80.8% | Dec 16, 2024 |
| Patrick Lamy | Senior VP, Commercial Strategy | $998K | -$70.5K | -6.6% | Dec 16, 2024 |
| Scott A. Gangloff | Chief Technology Officer | $756K | Dec 16, 2024 | ||
| G. Walmsley Graham | Director | $493K | Jun 8, 2024 | ||
| ATP Life Science Ventures, L.P. | 10%+ Owner | Jun 28, 2021 | |||
| Kevin Bitterman | Director | Jun 1, 2021 | |||
| Tomas J. Heyman | Director | Jun 8, 2024 | |||
| Jane Henderson | Director | Jun 8, 2024 | |||
| Yuan Xu | Director | Jun 8, 2024 | |||
| Seth Loring Harrison | Director | Jun 8, 2024 | |||
| Chou Judy | Director | Jun 8, 2024 | |||
| Mark T. Iwicki | Director | Jun 8, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|